Invivo on track to start bio scaffold clinical trial in Jan 2014

US based Invivo Therapeutics expects that the clinical trial of its first investigational product, a degradable polymer scaffold designed to promote healing following acute spinal cord injury, will be ready to enroll patients in the first quarter of 2014. –…

Asubio broadens inclusion criteria for spinal cord injury clinical trial

Asubio Pharmaceuticals Inc has now opened its clinical trial for the SUN13837 molecule to include AIS A, B and C injury to the cervical spine. The company is currently working with 45 acute trauma centers throughout the United States and Canada and…

Stem cell injections improve spinal injuries in rats

An international team led by researchers at the University of California, San Diego School of Medicine reports that a single injection of human neural stem cells produced neuronal regeneration and improvement of function and mobility in rats impaired by an…